D. E. Shaw & Co »

Rigel Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.7M 307k 28.33

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Palantir Technologies Cl A Call Option (PLTR)
Micron Technology Put Option (MU)
Tesla Motors (TSLA)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Booking Holdings (BKNG)
Robinhood Mkts Com Cl A Put Option (HOOD)
Amazon (AMZN)
Western Digital Put Option (WDC)

View all positions for D. E. Shaw & Co

Top funds holding Rigel Pharmaceuticals

BlackRock
Vanguard Group
Goldman Sachs Group
Armistice Capital
Acadian Asset Management
Marshall Wace
Capitolis Liquid Global Markets
State Street Corporation
Renaissance Technologies
Geode Capital Management
Qube Research & Technologies
Jane Street
Soleus Capital Management
D. E. Shaw & Co
Hillsdale Investment Management

View all funds holding Rigel Pharmaceuticals